4 HMO Stocks to Watch Despite Escalating Costs, Nursing Shortage

Industry Overview - The U.S. health insurance industry, known as Health Maintenance Organization (HMO), is focusing on technological innovation and pursuing mergers and acquisitions (M&A) to enhance capabilities and expand market presence [1][7] - The industry is experiencing rising medical expenses due to deferred care, chronic disease management, and increasing costs of specialty drugs [2][4] - The HMO industry consists of entities that provide basic and supplemental health services, assuming risks and assigning premiums to health insurance policies [3] Trends Impacting the Industry - Escalating medical expenses are driven by delayed medical procedures, increased demand for screenings, and a growing aging population, which is straining the Health Benefit Ratio and profit margins [4] - Regulatory changes, including the One Big Beautiful Bill Act, may tighten Medicaid eligibility and reduce ACA enrollment, impacting membership and reimbursements [5] - A nationwide shortage of healthcare professionals is affecting hospital operations and the quality of care, which could impact customer retention for HMOs [6] Strategic Initiatives - HMOs are increasingly focusing on M&A to broaden capabilities, enter new markets, and enhance their competitive advantage [7][8] - The Federal Reserve's interest rate cuts in 2025 are expected to lower borrowing costs, potentially fueling M&A activity in the industry [8] Industry Performance - The Zacks Medical-HMO industry has underperformed, declining 35.6% over the past year compared to the S&P 500's growth of 24.4% [12] - The industry's current valuation is at a forward P/E ratio of 13.71X, significantly lower than the S&P 500's 22.01X and the sector's 20.66X [15] Company Highlights - UnitedHealth Group: Revenue growth is supported by strong performance in its UnitedHealthcare and Optum segments, with a 2026 earnings estimate of $17.70 per share, indicating 8.3% growth [20][21] - Cigna: Thrives on the performance of its Evernorth and Cigna Healthcare platforms, with a 2026 earnings estimate of $30.29 per share, reflecting 1.5% growth [24][25] - Humana: Achieves consistent growth through higher premium revenues and a strong membership base, with a 2026 earnings estimate of $9.82 per share, indicating significant growth potential [29][30] - Centene: Revenue growth is driven by its Medicare and Medicaid businesses, with a 2026 earnings estimate of $3.01 per share, suggesting a 44.7% rise from the previous year [33][34]